nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.311	0.524	CbGaD
Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.283	0.477	CbGaD
Phentermine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0439	0.158	CbGbCtD
Phentermine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0439	0.158	CbGbCtD
Phentermine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0414	0.149	CbGbCtD
Phentermine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0401	0.144	CbGbCtD
Phentermine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0401	0.144	CbGbCtD
Phentermine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0358	0.128	CbGbCtD
Phentermine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0333	0.119	CbGbCtD
Phentermine—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.00244	0.0287	CcSEcCtD
Phentermine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.0125	CcSEcCtD
Phentermine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.0123	CcSEcCtD
Phentermine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.012	CcSEcCtD
Phentermine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.0119	CcSEcCtD
Phentermine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000955	0.0112	CcSEcCtD
Phentermine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.00095	0.0112	CcSEcCtD
Phentermine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000798	0.00938	CcSEcCtD
Phentermine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000776	0.00913	CcSEcCtD
Phentermine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.00902	CcSEcCtD
Phentermine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000767	0.00902	CcSEcCtD
Phentermine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000762	0.00896	CcSEcCtD
Phentermine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00076	0.00895	CcSEcCtD
Phentermine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00887	CcSEcCtD
Phentermine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000724	0.00852	CcSEcCtD
Phentermine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000707	0.00832	CcSEcCtD
Phentermine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000701	0.00824	CcSEcCtD
Phentermine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0007	0.00823	CcSEcCtD
Phentermine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000697	0.0082	CcSEcCtD
Phentermine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000692	0.00814	CcSEcCtD
Phentermine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000692	0.00814	CcSEcCtD
Phentermine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00809	CcSEcCtD
Phentermine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00809	CcSEcCtD
Phentermine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000675	0.00794	CcSEcCtD
Phentermine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000662	0.00779	CcSEcCtD
Phentermine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00749	CcSEcCtD
Phentermine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000633	0.00744	CcSEcCtD
Phentermine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000614	0.00722	CcSEcCtD
Phentermine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.0071	CcSEcCtD
Phentermine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00707	CcSEcCtD
Phentermine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000587	0.0069	CcSEcCtD
Phentermine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000584	0.00687	CcSEcCtD
Phentermine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00686	CcSEcCtD
Phentermine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000579	0.00681	CcSEcCtD
Phentermine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000574	0.00675	CcSEcCtD
Phentermine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00666	CcSEcCtD
Phentermine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000561	0.0066	CcSEcCtD
Phentermine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000556	0.00654	CcSEcCtD
Phentermine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000556	0.00654	CcSEcCtD
Phentermine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.00653	CcSEcCtD
Phentermine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000553	0.0065	CcSEcCtD
Phentermine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00637	CcSEcCtD
Phentermine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00633	CcSEcCtD
Phentermine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00633	CcSEcCtD
Phentermine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000533	0.00627	CcSEcCtD
Phentermine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000533	0.00627	CcSEcCtD
Phentermine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000532	0.00626	CcSEcCtD
Phentermine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000524	0.00616	CcSEcCtD
Phentermine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.00609	CcSEcCtD
Phentermine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00605	CcSEcCtD
Phentermine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00605	CcSEcCtD
Phentermine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00598	CcSEcCtD
Phentermine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.00593	CcSEcCtD
Phentermine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000504	0.00593	CcSEcCtD
Phentermine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00592	CcSEcCtD
Phentermine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00592	CcSEcCtD
Phentermine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.0059	CcSEcCtD
Phentermine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00581	CcSEcCtD
Phentermine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.00574	CcSEcCtD
Phentermine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00571	CcSEcCtD
Phentermine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000485	0.0057	CcSEcCtD
Phentermine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.0057	CcSEcCtD
Phentermine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00563	CcSEcCtD
Phentermine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.0056	CcSEcCtD
Phentermine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00559	CcSEcCtD
Phentermine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00558	CcSEcCtD
Phentermine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00557	CcSEcCtD
Phentermine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00557	CcSEcCtD
Phentermine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000469	0.00552	CcSEcCtD
Phentermine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000467	0.0055	CcSEcCtD
Phentermine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000467	0.00549	CcSEcCtD
Phentermine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.00549	CcSEcCtD
Phentermine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.00547	CcSEcCtD
Phentermine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00538	CcSEcCtD
Phentermine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00537	CcSEcCtD
Phentermine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00537	CcSEcCtD
Phentermine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00527	CcSEcCtD
Phentermine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00527	CcSEcCtD
Phentermine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00526	CcSEcCtD
Phentermine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00519	CcSEcCtD
Phentermine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.00518	CcSEcCtD
Phentermine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00516	CcSEcCtD
Phentermine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00516	CcSEcCtD
Phentermine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000437	0.00514	CcSEcCtD
Phentermine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000437	0.00514	CcSEcCtD
Phentermine—Ephedrine—ADRB2—chronic obstructive pulmonary disease	0.000436	0.115	CrCbGaD
Phentermine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00507	CcSEcCtD
Phentermine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000424	0.00499	CcSEcCtD
Phentermine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00497	CcSEcCtD
Phentermine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00485	CcSEcCtD
Phentermine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00476	CcSEcCtD
Phentermine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00476	CcSEcCtD
Phentermine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00473	CcSEcCtD
Phentermine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00467	CcSEcCtD
Phentermine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00464	CcSEcCtD
Phentermine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00464	CcSEcCtD
Phentermine—Phenylpropanolamine—ADRB2—chronic obstructive pulmonary disease	0.000391	0.103	CrCbGaD
Phentermine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00458	CcSEcCtD
Phentermine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00455	CcSEcCtD
Phentermine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00455	CcSEcCtD
Phentermine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00454	CcSEcCtD
Phentermine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00454	CcSEcCtD
Phentermine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00454	CcSEcCtD
Phentermine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0045	CcSEcCtD
Phentermine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0045	CcSEcCtD
Phentermine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.0045	CcSEcCtD
Phentermine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00445	CcSEcCtD
Phentermine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00445	CcSEcCtD
Phentermine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00441	CcSEcCtD
Phentermine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.0044	CcSEcCtD
Phentermine—Pseudoephedrine—TNF—chronic obstructive pulmonary disease	0.000373	0.0981	CrCbGaD
Phentermine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.00438	CcSEcCtD
Phentermine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00438	CcSEcCtD
Phentermine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00436	CcSEcCtD
Phentermine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00436	CcSEcCtD
Phentermine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00433	CcSEcCtD
Phentermine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000367	0.00432	CcSEcCtD
Phentermine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00431	CcSEcCtD
Phentermine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00429	CcSEcCtD
Phentermine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00429	CcSEcCtD
Phentermine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00425	CcSEcCtD
Phentermine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00418	CcSEcCtD
Phentermine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00418	CcSEcCtD
Phentermine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00416	CcSEcCtD
Phentermine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00416	CcSEcCtD
Phentermine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00415	CcSEcCtD
Phentermine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00412	CcSEcCtD
Phentermine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00411	CcSEcCtD
Phentermine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00411	CcSEcCtD
Phentermine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.00411	CcSEcCtD
Phentermine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000348	0.0041	CcSEcCtD
Phentermine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00409	CcSEcCtD
Phentermine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00408	CcSEcCtD
Phentermine—Tranylcypromine—CYP1A2—chronic obstructive pulmonary disease	0.000344	0.0905	CrCbGaD
Phentermine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00401	CcSEcCtD
Phentermine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00395	CcSEcCtD
Phentermine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00393	CcSEcCtD
Phentermine—Pseudoephedrine—ADRB2—chronic obstructive pulmonary disease	0.000331	0.087	CrCbGaD
Phentermine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00388	CcSEcCtD
Phentermine—Phenylpropanolamine—CYP1A2—chronic obstructive pulmonary disease	0.000324	0.0851	CrCbGaD
Phentermine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00378	CcSEcCtD
Phentermine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00378	CcSEcCtD
Phentermine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000315	0.0037	CcSEcCtD
Phentermine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00796	CbGpPWpGaD
Phentermine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.0036	CcSEcCtD
Phentermine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000306	0.0036	CcSEcCtD
Phentermine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000306	0.00789	CbGpPWpGaD
Phentermine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00357	CcSEcCtD
Phentermine—Pseudoephedrine—SLC6A4—chronic obstructive pulmonary disease	0.0003	0.079	CrCbGaD
Phentermine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00353	CcSEcCtD
Phentermine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00348	CcSEcCtD
Phentermine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00348	CcSEcCtD
Phentermine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00341	CcSEcCtD
Phentermine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.0034	CcSEcCtD
Phentermine—Benzyl alcohol—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.0759	CrCbGaD
Phentermine—SLC6A2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000288	0.00742	CbGpPWpGaD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000287	0.00741	CbGpPWpGaD
Phentermine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00336	CcSEcCtD
Phentermine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00335	CcSEcCtD
Phentermine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00335	CcSEcCtD
Phentermine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00332	CcSEcCtD
Phentermine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00332	CcSEcCtD
Phentermine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00332	CcSEcCtD
Phentermine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00332	CcSEcCtD
Phentermine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00028	0.0033	CcSEcCtD
Phentermine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.0033	CcSEcCtD
Phentermine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00329	CcSEcCtD
Phentermine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00719	CbGpPWpGaD
Phentermine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00719	CbGpPWpGaD
Phentermine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00328	CcSEcCtD
Phentermine—Benzyl alcohol—CYP1A2—chronic obstructive pulmonary disease	0.000278	0.0731	CrCbGaD
Phentermine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00325	CcSEcCtD
Phentermine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00325	CcSEcCtD
Phentermine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00323	CcSEcCtD
Phentermine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000272	0.0032	CcSEcCtD
Phentermine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00319	CcSEcCtD
Phentermine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00316	CcSEcCtD
Phentermine—Selegiline—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.0702	CrCbGaD
Phentermine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00314	CcSEcCtD
Phentermine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00313	CcSEcCtD
Phentermine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00313	CcSEcCtD
Phentermine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00313	CcSEcCtD
Phentermine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00312	CcSEcCtD
Phentermine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00306	CcSEcCtD
Phentermine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00302	CcSEcCtD
Phentermine—SLC6A3—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000255	0.00658	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000253	0.00652	CbGpPWpGaD
Phentermine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00295	CcSEcCtD
Phentermine—MAOB—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00025	0.00645	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000248	0.0064	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.0064	CbGpPWpGaD
Phentermine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000247	0.0029	CcSEcCtD
Phentermine—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000244	0.0641	CrCbGaD
Phentermine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.00285	CcSEcCtD
Phentermine—SLC6A4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000239	0.00615	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.00615	CbGpPWpGaD
Phentermine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00278	CcSEcCtD
Phentermine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00609	CbGpPWpGaD
Phentermine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00602	CbGpPWpGaD
Phentermine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000231	0.00596	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000227	0.00585	CbGpPWpGaD
Phentermine—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000226	0.0594	CrCbGaD
Phentermine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00579	CbGpPWpGaD
Phentermine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00574	CbGpPWpGaD
Phentermine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00258	CcSEcCtD
Phentermine—SLC6A4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000218	0.00563	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00554	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000214	0.00551	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000213	0.0055	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000213	0.0055	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000212	0.00546	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00542	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00537	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000207	0.00533	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000205	0.00529	CbGpPWpGaD
Phentermine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00233	CcSEcCtD
Phentermine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000198	0.00511	CbGpPWpGaD
Phentermine—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.0051	CbGpPWpGaD
Phentermine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00227	CcSEcCtD
Phentermine—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00019	0.0049	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000189	0.00488	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000189	0.00487	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000188	0.00484	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000188	0.00484	CbGpPWpGaD
Phentermine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00219	CcSEcCtD
Phentermine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000185	0.00477	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000182	0.00469	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00465	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.00018	0.00465	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000178	0.00459	CbGpPWpGaD
Phentermine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00207	CcSEcCtD
Phentermine—MAOB—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000175	0.00452	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000175	0.0045	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000174	0.0045	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000174	0.00448	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00447	CbGpPWpGaD
Phentermine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00202	CcSEcCtD
Phentermine—SLC6A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000167	0.00431	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000166	0.00429	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000166	0.00428	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000163	0.00421	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000162	0.00417	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000161	0.00415	CbGpPWpGaD
Phentermine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00189	CcSEcCtD
Phentermine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00187	CcSEcCtD
Phentermine—MAOA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000159	0.00409	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000158	0.00407	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000158	0.00406	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000157	0.00404	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000157	0.00404	CbGpPWpGaD
Phentermine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00182	CcSEcCtD
Phentermine—SLC6A2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000155	0.004	CbGpPWpGaD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.000155	0.00399	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000155	0.00398	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000153	0.00394	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00394	CbGpPWpGaD
Phentermine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.0018	CcSEcCtD
Phentermine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.0018	CcSEcCtD
Phentermine—MAOB—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00394	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000152	0.00392	CbGpPWpGaD
Phentermine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00179	CcSEcCtD
Phentermine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00179	CcSEcCtD
Phentermine—SLC6A4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000151	0.00389	CbGpPWpGaD
Phentermine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00177	CcSEcCtD
Phentermine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00379	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000144	0.00372	CbGpPWpGaD
Phentermine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00169	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000144	0.0037	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000141	0.00363	CbGpPWpGaD
Phentermine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00165	CcSEcCtD
Phentermine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00164	CcSEcCtD
Phentermine—SLC6A3—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000137	0.00354	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000136	0.00352	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000135	0.00349	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000133	0.00344	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00344	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000133	0.00344	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00341	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.0034	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00339	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00339	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00336	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00013	0.00335	CbGpPWpGaD
Phentermine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00149	CcSEcCtD
Phentermine—SLC6A3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000124	0.00319	CbGpPWpGaD
Phentermine—MAOB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000123	0.00317	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000121	0.00312	CbGpPWpGaD
Phentermine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00142	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000118	0.00304	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00301	CbGpPWpGaD
Phentermine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00137	CcSEcCtD
Phentermine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000116	0.00298	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000115	0.00296	CbGpPWpGaD
Phentermine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00132	CcSEcCtD
Phentermine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00287	CbGpPWpGaD
Phentermine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00131	CcSEcCtD
Phentermine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00131	CcSEcCtD
Phentermine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00011	0.0013	CcSEcCtD
Phentermine—MAOA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00284	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000109	0.00282	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00276	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00276	CbGpPWpGaD
Phentermine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00123	CcSEcCtD
Phentermine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00262	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00262	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00262	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00261	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.0001	0.00258	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.89e-05	0.00255	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.69e-05	0.0025	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	9.67e-05	0.00249	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.6e-05	0.00248	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.58e-05	0.00247	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.56e-05	0.00247	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.49e-05	0.00245	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.48e-05	0.00244	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.96e-05	0.00231	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	8.35e-05	0.00215	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.21e-05	0.00212	CbGpPWpGaD
Phentermine—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.14e-05	0.0021	CbGpPWpGaD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.1e-05	0.00209	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	7.92e-05	0.00204	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.00202	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.78e-05	0.00201	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	7.71e-05	0.00199	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.36e-05	0.0019	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.29e-05	0.00188	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	7.03e-05	0.00181	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.99e-05	0.0018	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.93e-05	0.00179	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.91e-05	0.00178	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.85e-05	0.00177	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.83e-05	0.00176	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.77e-05	0.00175	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.65e-05	0.00172	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.37e-05	0.00164	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.98e-05	0.00154	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.92e-05	0.00153	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.85e-05	0.00151	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.78e-05	0.00149	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.74e-05	0.00148	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.73e-05	0.00148	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.73e-05	0.00148	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.69e-05	0.00147	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.66e-05	0.00146	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.62e-05	0.00145	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.61e-05	0.00145	CbGpPWpGaD
Phentermine—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.11e-05	0.00132	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.07e-05	0.00131	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	4.97e-05	0.00128	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.93e-05	0.00127	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.91e-05	0.00127	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.85e-05	0.00125	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.81e-05	0.00124	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.79e-05	0.00123	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.75e-05	0.00123	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.75e-05	0.00122	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.72e-05	0.00122	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.68e-05	0.00121	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.62e-05	0.00119	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.00113	CbGpPWpGaD
Phentermine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	4.38e-05	0.0918	CbGeAlD
Phentermine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.37e-05	0.00113	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.36e-05	0.00113	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.36e-05	0.00112	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.35e-05	0.00112	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.34e-05	0.00112	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.32e-05	0.00112	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.3e-05	0.00111	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.28e-05	0.0011	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.28e-05	0.0011	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	4.27e-05	0.0011	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.00108	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.16e-05	0.00107	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.16e-05	0.00107	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.14e-05	0.00107	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.11e-05	0.00106	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.11e-05	0.00106	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.1e-05	0.00106	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.00105	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.07e-05	0.00105	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.07e-05	0.00105	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.06e-05	0.00105	CbGpPWpGaD
Phentermine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	4.02e-05	0.0841	CbGeAlD
Phentermine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4e-05	0.00103	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.9e-05	0.00101	CbGpPWpGaD
Phentermine—MAOB—respiratory system—chronic obstructive pulmonary disease	3.82e-05	0.08	CbGeAlD
Phentermine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.000961	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.68e-05	0.000949	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.68e-05	0.000948	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.65e-05	0.000942	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.59e-05	0.000927	CbGpPWpGaD
Phentermine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	3.54e-05	0.0741	CbGeAlD
Phentermine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.000911	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000899	CbGpPWpGaD
Phentermine—MAOB—connective tissue—chronic obstructive pulmonary disease	3.36e-05	0.0704	CbGeAlD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.36e-05	0.000865	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.36e-05	0.000865	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.34e-05	0.000862	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.33e-05	0.000858	CbGpPWpGaD
Phentermine—MAOA—respiratory system—chronic obstructive pulmonary disease	3.26e-05	0.0682	CbGeAlD
Phentermine—MAOB—bronchus—chronic obstructive pulmonary disease	3.14e-05	0.0658	CbGeAlD
Phentermine—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	3e-05	0.000773	CbGpPWpGaD
Phentermine—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.96e-05	0.000762	CbGpPWpGaD
Phentermine—MAOA—connective tissue—chronic obstructive pulmonary disease	2.87e-05	0.0601	CbGeAlD
Phentermine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.84e-05	0.000733	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.75e-05	0.00071	CbGpPWpGaD
Phentermine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	2.72e-05	0.0569	CbGeAlD
Phentermine—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.71e-05	0.0007	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.68e-05	0.000692	CbGpPWpGaD
Phentermine—MAOA—bronchus—chronic obstructive pulmonary disease	2.68e-05	0.0562	CbGeAlD
Phentermine—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.61e-05	0.000673	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.49e-05	0.000643	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.45e-05	0.000631	CbGpPWpGaD
Phentermine—MAOA—trachea—chronic obstructive pulmonary disease	2.41e-05	0.0504	CbGeAlD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.37e-05	0.000612	CbGpPWpGaD
Phentermine—SLC6A3—lung—chronic obstructive pulmonary disease	2.33e-05	0.0487	CbGeAlD
Phentermine—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.26e-05	0.000582	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.22e-05	0.000573	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.21e-05	0.00057	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.2e-05	0.000568	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000564	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.16e-05	0.000558	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.14e-05	0.000553	CbGpPWpGaD
Phentermine—SLC6A4—lung—chronic obstructive pulmonary disease	2.13e-05	0.0447	CbGeAlD
Phentermine—MAOB—lung—chronic obstructive pulmonary disease	2.03e-05	0.0425	CbGeAlD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000523	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.01e-05	0.000518	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.99e-05	0.000514	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000486	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.88e-05	0.000485	CbGpPWpGaD
Phentermine—SLC6A2—lung—chronic obstructive pulmonary disease	1.88e-05	0.0393	CbGeAlD
Phentermine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.85e-05	0.000478	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000472	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	1.78e-05	0.000458	CbGpPWpGaD
Phentermine—MAOA—lung—chronic obstructive pulmonary disease	1.73e-05	0.0362	CbGeAlD
Phentermine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.73e-05	0.000446	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000439	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.7e-05	0.000438	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.000423	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000409	CbGpPWpGaD
Phentermine—CYP1A2—lung—chronic obstructive pulmonary disease	1.44e-05	0.0302	CbGeAlD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.00035	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.18e-05	0.000305	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.17e-05	0.000302	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.17e-05	0.000301	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000299	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000287	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000278	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.07e-05	0.000275	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	0.000275	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000272	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000258	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-06	0.000255	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.82e-06	0.000253	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.73e-06	0.000251	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.22e-06	0.000238	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.03e-06	0.000233	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.19e-06	0.000211	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.12e-06	0.000209	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.08e-06	0.000208	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.01e-06	0.000206	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.52e-06	0.000194	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.46e-06	0.000192	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.13e-06	0.000184	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.07e-06	0.000182	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.94e-06	0.000179	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-06	0.000176	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.37e-06	0.000164	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-06	0.000156	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.85e-06	0.000125	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.81e-06	0.000124	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.64e-06	0.00012	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.6e-06	0.000119	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	0.000106	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	0.000101	CbGpPWpGaD
